We spoke with Guido Baechler, CEO & Director of Mainz BioMed, a newly  listed company (NASDAQ : MYNZ) behind the breakthrough product Colo Alert, an early-detection cancer screening tool. Guido updated us on additions to the leadership group and announced an exciting new partnership with Precision for Medicine to expedite FDA approval.   

Dylan Berg  Founder, Dear Retail  

Twitter: @Dylan_berg  www.dearretailinvestors.com      

Guido Baechler CEO & Director, Mainz BioMed  

mainzbiomed.com  Nasdaq: MYNZ